Kirkpatrick Lynn
- SEC CIK
- 0001418785
No open-market purchases or sales filed in the past year.
Current role at each company
- ENSC Ensysce Biosciences, Inc.Chief Executive Officeras of May 27, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Kirkpatrick Lynn as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 27, 2022 (view filing)2:05 PM ET | May 25-26 | 2 days | Kirkpatrick LynnChief Executive Officer | PPurchase | +97.0K | $0.4979 | +$48.3K | +34.1%381.9K after | 2 lots |